Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market
Holding PRME?
Track your performance easily

Prime Medicine, Inc. (PRME) Financial Statements

541 Followers

Prime Medicine, Inc. Financial Overview

Prime Medicine, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.128; its P/E ratio is -1.96; Prime Medicine, Inc. is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Mar 23
Income Statement-
Total Revenue-$ 591.00K$ 168.00K--
Gross Profit-$ 591.00K$ 168.00K--
EBIT$ -55.46M$ -46.79M$ -114.21M$ -9.85M$ -39.60M
EBITDA$ -50.76M$ -42.80M$ -110.70M$ -6.39M$ -36.33M
Net Income Common Stockholders$ -55.33M$ -45.76M$ -65.64M$ -50.71M$ -78.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 55.60M$ 94.16M$ 41.57M$ 43.96M$ 249.52M
Total Assets$ 259.70M$ 311.38M$ 193.85M$ 239.15M$ 316.95M
Total Debt$ 41.58M$ 43.79M$ 13.63M$ 17.04M$ 25.96M
Net Debt$ -14.02M$ -50.37M$ -27.94M$ -26.92M$ -223.55M
Total Liabilities$ 63.12M$ 67.62M$ 60.78M$ 45.19M$ 38.15M
Stockholders Equity$ 196.59M$ 243.77M$ 133.07M$ 193.96M$ 278.80M
Cash Flow-
Free Cash Flow$ -47.39M$ -70.03M$ -45.70M$ -42.08M$ -43.56M
Operating Cash Flow$ -45.49M$ -67.71M$ -43.86M$ -39.17M$ -41.56M
Investing Cash Flow$ 6.89M$ -37.03M$ 41.28M$ -37.77M$ -12.66M
Financing Cash Flow$ 35.00K$ 157.33M$ 194.00K$ 318.00K$ 68.00K
Currency in USD

Prime Medicine, Inc. Earnings and Revenue History

Prime Medicine, Inc. Debt to Assets

Prime Medicine, Inc. Cash Flow

Prime Medicine, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis